Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Zahraa H. F. Al-Saedi"'
Autor:
Rinda Devi Bachu, Pallabitha Chowdhury, Zahraa H. F. Al-Saedi, Pradeep K. Karla, Sai H. S. Boddu
Publikováno v:
Pharmaceutics, Vol 10, Iss 1, p 28 (2018)
Ocular drug delivery is challenging due to the presence of anatomical and physiological barriers. These barriers can affect drug entry into the eye following multiple routes of administration (e.g., topical, systemic, and injectable). Topical adminis
Externí odkaz:
https://doaj.org/article/280237989c354b5e86bd5a743ee34147
Autor:
Sai H.S. Boddu, Reginald F. Baugh, Rinda Devi Bachu, Allison Zimmerman, Surajit Dey, Zahoor A. Shah, Zahraa H F Al-Saedi
Publikováno v:
Current Pharmaceutical Design. 22:4470-4490
Dry eye disease (DED) is a tear film disorder resulting in hyperosmolarity of the tear film and inflammation of the ocular surface. DED is also referred to as keratoconjunctivitis sicca (KCS) and dry eye syndrome. DED represents a significant public
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::074b4ecfa3a408b19bac586299faf936
https://doi.org/10.2174/1381612822666160614012634
https://doi.org/10.2174/1381612822666160614012634
Autor:
Sai H.S. Boddu, Rinda Devi Bachu, Pradeep K. Karla, Zahraa H F Al-Saedi, Pallabitha Chowdhury
Publikováno v:
Pharmaceutics
Pharmaceutics, Vol 10, Iss 1, p 28 (2018)
Pharmaceutics, Vol 10, Iss 1, p 28 (2018)
Ocular drug delivery is challenging due to the presence of anatomical and physiological barriers. These barriers can affect drug entry into the eye following multiple routes of administration (e.g., topical, systemic, and injectable). Topical adminis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e41c3262ae06725ec315fbb72d472af7
https://pubmed.ncbi.nlm.nih.gov/29495528
https://pubmed.ncbi.nlm.nih.gov/29495528
Publikováno v:
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics. 32(7)
The aim of this study was to develop and characterize a novel sustained-release drug delivery system of cyclosporine-A (CsA) using hydroxypropyl methylcellulose (HPMC) and xanthan gum (XG) for treating dry eye disease (DED).Polymeric inserts of CsA w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3117ba9c8d107d78de8786dcebb3fbe2
https://pubmed.ncbi.nlm.nih.gov/27294697
https://pubmed.ncbi.nlm.nih.gov/27294697